1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
American Cancer Society RFA: ACS Catalyst Award is sponsored by American Cancer Society and Cancer Research UK. Sustain research of early‑stage investigators with high‑scoring but unfunded ACS‑RSG or NCI‑R01 projects.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
RFA: American Cancer Society Catalyst Awards | American Cancer Society https://searchapi. cancer. org Use double-quotes ("") around a phrase for an exact result Our 24/7 cancer helpline provides information and answers for people dealing with cancer.
We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear. Live Chat available weekdays, 7:00 am - 6:30 pm CT Call us at 1-800-227-2345 Available any time of day or night Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat.
We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include: Referrals to patient-related programs or resources Donations, website, or event-related assistance For medical questions, we encourage you to review our information with your doctor.
Research We Fund: Extramural Discovery Science (EDS) Apply for a Research Grant Arizona (AZ) Discovery Boost Grants (DBG) ASTRO-ACS Clinician Scientist Development Grant (CSDG) Clinician Scientist Development Grant (CSDG) Discovery Boost Grants (DBG) HEALED Gold Medal RFA To Support Mind-Body-Spirit Wellness in Cancer Survivors Institutional Research Grants Mission Boost Grants (MBG) RFA: ACS IMPACT - Expanding Prostate Cancer Clinical Trials in the Community RFA: Extramural Discovery Science Accelerator Award RFA: Leukemia Exploration and Prevention Grant Program (LEAP) TheoryLab Collaborative (TLC) Grant RFA: Cancer Health Research Centers (CHERCs) RFA: Biology to Prevention Award (CRUK) RFA: ACS - Fanconi Cancer Foundation Discovery Boost Grant RFA: American Cancer Society Catalyst Awards RFA: American Cancer Society - Flatiron Real-World Data Impact Award Extramural Grants Department Staff Contacts Definition of Research Areas FAQs: ACS Extramural Discovery Science and Grant Application Submissions Extramural Priority Research Areas American Cancer Society Research Events EDS: Our Research Programs Career Growth and Research Excellence Program Institutional Research Grants (IRG) Cancer Detection and Experimental Therapeutics (PF-CDET) Cell Biology and Immunology (PF-CBI) Clinical and Population Sciences (PF-CPS) Molecular Biology and Biochemistry (PF-MBB) Biochemistry and Immunology of Cancer Program DNA Mechanisms in Cancer (DMC) PRC Immunology and Blood Cell Development (IBCD) PRC RNA Mechanisms in Cancer (RMC) PRC Tumor Biochemistry and Endocrinology (TBE) PRC Mission Boost Grants (MBG) PRC Cell Biology and Preclinical Cancer Research Program Cancer Cell Biology (CCB) PRC Cancer Detection and Progression (CDP) PRC Experimental Therapeutics (ET) PRC Metastasis and Microenvironment (MM) PRC Clinical and Population Sciences Program Cancer Prevention and Health Promotion (CPHP) PRC Treatment, Palliative Care, and Survivorship Research (CTPS) Etiology, Screening, and Early Detection (ESED) Healthcare Outcomes, Policy, and Systems Research (HOPS) Peer Review Committees (PRCs) Discovery Scientific Council Community Research Partner Participation American Cancer Society Professors Nobel Laureates and the American Cancer Society American Cancer Society-Jiler Professors & Fellows Conference RFA: American Cancer Society Catalyst Awards The American Cancer Society (ACS) has a longstanding commitment to fund impactful cancer research and invest in the careers of researchers, often early on in their careers.
We recognize that there has been a decrease in available funding for cancer research, resulting in a surplus of innovative and potentially impactful research projects that have gone unfunded. To this end, the ACS announced the ACS Catalyst Award. Application Deadline: Jan.
5, 2026 Application Review: Feb. 2026 Anticipated Grant Start: May 1, 2026 The purpose of the Catalyst Award opportunity is to catalyze the research of early-stage investigators with high-scoring, but unfunded research projects recently submitted to either the ACS Research Scholar Grant or the National Cancer Institute (NCI) R01 grant funding mechanisms.
Through the Catalyst Awards, ACS intends to sustain the projects and investigators as they continue to apply for research grants, including resubmissions of their unfunded proposals. The applicant must clearly articulate and justify the need for the ACS Catalyst Award. The requested funds must support the project and fall within the scope of the proposed grant initially submitted to either ACS or NCI.
Applications will be accepted in all areas of cancer research. Applicants are encouraged to review the Catalyst Policies document for all information on institution and applicant eligibility requirements. The principal investigator must have a doctoral degree, work at a US academic institution or eligible nonprofit, and have an independent faculty appointment (or equivalent position).
In addition, the applicant must meet one of these situations: Must have applied for an ACS Research Scholar Grant in 2024-2025 and received a review score of Outstanding, had their application moved forward for funding consideration, but the application was not funded (i.e., the application was given a status of contingent) Must have applied for an NIH R01 to the NCI in 2024-2025 and scored at or below the 15 th percentile but did not receive funding.
Eligibility Requirements for Research Scholar Grants Applicants must also meet the eligibility criteria for the ACS Research Scholar Grant: Must be within 10 years of their initial independent research/independent full-time faculty appointment (or equivalent). Must currently be in an independent research position/faculty position at an eligible US institution. See the Catalyst Award policies for the guidelines for independence.
Cannot be the PI (MPI in included) of more than 1 R01/R01-equivalent award at the time of the application deadline. An R01-equivalent is a research project grant of more than $100,000 direct costs per year for more than 3 years.
Exceptions: Start-up funding, mentored or training awards, awards intended to primarily support the salary of the applicant, and company-sponsored clinical trials that are not investigator-initiated are excluded from this definition. The scope of the ACS Catalyst Award submission cannot be currently funded by another funding agency. Current or former ACS Catalyst Award grantees are not eligible to apply.
Each award is for one year and $150,000 direct costs only. Indirect costs cannot be claimed. All application instructions and materials are located on ProposalCentral , and eligible applicants will be given access to the materials by the ACS.
Applicants must discuss applying with the ACS to be given access to the application materials. Application Deadline: January 5, 2026 Catalyst Award Application Instructions and Catalyst Award Policies ACS Research Scholar Grant applicants should work directly with their ACS scientific program office. NIH R01 applicants may contact Doug Hurst, PhD, at doug.
hurst@cancer. org . Help us end cancer as we know it, for everyone.
According to the current listing, eligibility includes: Individual independent investigators within first 8 years of independent appointment. Confirm the full requirements in the official notice before applying.
The current listing shows up to $860,000 direct costs over 5 years plus 10% indirect costs. Verify award ceilings, matching requirements, and allowable costs in the official notice.
American Cancer Society RFA: ACS Catalyst Award is funded by American Cancer Society and Cancer Research UK. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article